Teratogenic drugs inhibit tumour cell attachment to lectin-coated surfaces
- PMID: 503229
- DOI: 10.1038/282507a0
Teratogenic drugs inhibit tumour cell attachment to lectin-coated surfaces
Abstract
Interactions between embryonic cells are generally thought to have a central role in the control of development. When these morphogenic interactions are interrupted by either physical intervention or genetic defects, normal development is impaired. In accord with these experiments, specific interactions between embryonic cells have been demonstrated in several in vitro systems. Many investigators have described homotypic aggregation of chick embryo cells, and heterotypic specificity has been described. Because of the importance of morphogenic cell-cell interactions in development it follows that agents that interfere with these interactions, regardless of the interference mechanism, are potential teratogens. Here we have used a simple in vitro cell to surface recognition system in an attempt to screen for potential teratogens. We have found a very high correlation between inhibitory activity in the in vitro assay and reported teratogenic activity in human or animal studies. This suggests that many teratogenic agents may act by interfering, in an as yet unknown way, in normal cell to cell interactions.
Similar articles
-
In vitro screening assay for teratogens using growth inhibition of human embryonic cells.Proc Natl Acad Sci U S A. 1985 Sep;82(17):5791-4. doi: 10.1073/pnas.82.17.5791. Proc Natl Acad Sci U S A. 1985. PMID: 3862095 Free PMC article.
-
Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents.Proc Natl Acad Sci U S A. 1982 Mar;79(6):2056-60. doi: 10.1073/pnas.79.6.2056. Proc Natl Acad Sci U S A. 1982. PMID: 6952253 Free PMC article.
-
Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.Birth Defects Res B Dev Reprod Toxicol. 2004 Apr;71(2):69-79. doi: 10.1002/bdrb.20000. Birth Defects Res B Dev Reprod Toxicol. 2004. PMID: 15098200
-
A review of advances in prescreening for teratogenic hazards.Prog Drug Res. 1985;29:121-54. doi: 10.1007/978-3-0348-9315-2_5. Prog Drug Res. 1985. PMID: 3911260 Review. No abstract available.
-
Teratological research using in vitro systems. IV. Cells in culture.Environ Health Perspect. 1987 Jun;72:225-35. doi: 10.1289/ehp.8772225. Environ Health Perspect. 1987. PMID: 3113933 Free PMC article. Review.
Cited by
-
PBB inhibits metabolic cooperation in Chinese hamster cells in vitro: its potential as a tumor promoter.Environ Health Perspect. 1981 Jan;37:179-82. doi: 10.1289/ehp.8137179. Environ Health Perspect. 1981. PMID: 6257504 Free PMC article.
-
In vitro screening assay for teratogens using growth inhibition of human embryonic cells.Proc Natl Acad Sci U S A. 1985 Sep;82(17):5791-4. doi: 10.1073/pnas.82.17.5791. Proc Natl Acad Sci U S A. 1985. PMID: 3862095 Free PMC article.
-
Chemical and toxicological characterization of residential oil burner emissions: II. Mutagenic, tumorigenic, and potential teratogenic activity.Environ Health Perspect. 1987 Aug;73:235-46. doi: 10.1289/ehp.8773235. Environ Health Perspect. 1987. PMID: 3665866 Free PMC article.
-
Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.Drug Saf. 1992 Mar-Apr;7(2):116-34. doi: 10.2165/00002018-199207020-00004. Drug Saf. 1992. PMID: 1605898 Review.
-
Generation of biologically active substances in a natural gas flame.Environ Health Perspect. 1987 Jun;72:297-303. doi: 10.1289/ehp.8772297. Environ Health Perspect. 1987. PMID: 3622438 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources